Compare GKOS & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | GTES |
|---|---|---|
| Founded | 1998 | 1911 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.8B |
| IPO Year | 2015 | 2018 |
| Metric | GKOS | GTES |
|---|---|---|
| Price | $107.89 | $22.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $122.08 | $26.45 |
| AVG Volume (30 Days) | 1.1M | ★ 2.4M |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.34 |
| EPS | N/A | ★ 0.91 |
| Revenue | $469,820,000.00 | ★ $3,416,400,000.00 |
| Revenue This Year | $30.89 | $3.05 |
| Revenue Next Year | $24.36 | $3.62 |
| P/E Ratio | ★ N/A | $24.49 |
| Revenue Growth | ★ 30.38 | N/A |
| 52 Week Low | $73.16 | $14.70 |
| 52 Week High | $163.71 | $26.46 |
| Indicator | GKOS | GTES |
|---|---|---|
| Relative Strength Index (RSI) | 73.56 | 44.65 |
| Support Level | $104.11 | $21.10 |
| Resistance Level | $107.18 | $22.89 |
| Average True Range (ATR) | 4.40 | 0.56 |
| MACD | 1.26 | 0.17 |
| Stochastic Oscillator | 92.97 | 60.33 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.